Navigation Links
Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
Date:11/24/2009

SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 21st Annual Piper Jaffray Health Care Conference in New York.

The live presentation takes place Tuesday, December 1, 2009 at 4:30 p.m. Eastern Time (ET)/1:30 p.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports Third Quarter 2009 Results
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
3. Neurocrine Biosciences Presents Elagolix Data
4. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
5. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
6. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
7. Neurocrine Biosciences Reports First Quarter 2008 Results
8. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
9. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
10. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
11. Cell Biosciences Completes Acquisition of Alpha Innotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2020)... ... 12, 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a ... Ventures, Inc, operating under a tender from the Israeli Innovation Authority (IIA) has ... at Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach ... Counselor Association, will celebrate high school counselors and award the first annual Excellence ... National Championship weekend and Extra Yard for Teachers Summit celebration on Saturday, January ...
(Date:1/10/2020)... ... 2020 , ... By mid-January, many people’s New Year’s resolutions have fallen by the wayside. ... Night Wellness Retreat for the 2020 season. , Open each year from the last spring ... in May and the first weekend of October. The new dates for New Life Hiking ...
Breaking Medicine Technology:
(Date:1/24/2020)... CITY (PRWEB) , ... January 24, 2020 , ... ... as one of the Healthiest Employers of Utah in 2019. , PRMI ... organizations that prioritize their employees’ health. The program analyzes companies’ adoption of programs ...
(Date:1/24/2020)... ... January 24, 2020 , ... SweetLeaf Stevia Sweetener, the ... best-selling nutrition author Jorge Cruise to educate consumers on losing weight through better ... advocate of intermittent fasting, that is fat burning and boosting your energy, and ...
(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening of ... of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location will ... It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper Canyon, ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Santa Rosa, California. ... facility features and amenities. , According to the Alzheimer’s Association , ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... of providing programs and services that improve workforce resilience, is presenting at the ... serves as an advocate and resource for organizations that devote themselves to society’s ...
Breaking Medicine News(10 mins):